Document detail
ID

doi:10.1186/s40694-024-00175-4...

Author
Masi, Audrey Wögerbauer, Klara Mach, Robert L. Mach-Aigner, Astrid R.
Langue
en
Editor

BioMed Central

Category

Mycology

Year

2024

listing date

6/5/2024

Keywords
fungal transformation protoplasts ... crispr/cas9 golden gate assembly ama1 plasmid gene system genomic deletions pullulans
Metrics

Abstract

Background Aureobasidium pullulans is a generalist polyextremotolerant black yeast fungus.

It tolerates temperatures below 0 °C or salt concentrations up to 18%, among other stresses.

A. pullulans genome sequencing revealed a high potential for producing bioactive metabolites.

Only few molecular tools exist to edit the genome of A. pullulans , hence it is important to make full use of its potential.

Two CRISPR/Cas9 methods have been proposed for the protoplast-based transformation of A. pullulans .

These methods require the integration of a marker gene into the locus of the gene to be deleted, when the deletion of this gene does not yield a selectable phenotype.

We present the adaptation of a plasmid-based CRISPR/Cas9 system developed in Aspergillus niger for A. pullulans to create deletion strains.

Results The A. niger CRISPR/Cas9 plasmid led to efficient genomic deletions in A. pullulans.

In this study, strains with deletions ranging from 30 to 862 bp were obtained by using an AMA1 plasmid-based genome editing strategy.

Conclusion The CRISPR/Cas9 transformation system presented in this study provides new opportunities for strain engineering of A. pullulans.

This system allows expression of Cas9 and antibiotic resistance while being easy to adapt.

This strategy could open the path to intensive genomic engineering in A. pullulans .

Masi, Audrey,Wögerbauer, Klara,Mach, Robert L.,Mach-Aigner, Astrid R., 2024, Genomic deletions in Aureobasidium pullulans by an AMA1 plasmid for gRNA and CRISPR/Cas9 expression, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis